InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Monday, 02/11/2019 5:25:18 PM

Monday, February 11, 2019 5:25:18 PM

Post# of 4875
GILD’s Selonsertib—(ASK1 inhibitor)—fails phase-3 in NASH patients with cirrhosis:

#msg-146757072

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News